跳至主要内容
临床试验/JPRN-UMIN000053483
JPRN-UMIN000053483已完成Unknown

Cost-effectiveness study of atezolizumab vs. durvalumab : real-world data on first-line chemotherapy combined with immune-checkpoint inhibitors for extensive disease small-cell lung cancer - cost effectiveness study of chemocherapy combined with immune checkpoint inhivitors for extensive disease small cell lung cancer

Kobe Minimally Invasive Cancer Center0 个研究点目标入组 200 人开始时间: 2024年1月30日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18years-old 至 100years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Cases judged by researchers at each institution to be inappropriate for registration.

研究者

发起方
Kobe Minimally Invasive Cancer Center

相似试验

进行中(未招募)
1 期
Cost-effectiveness of adalimumab and surgery compared with adalimumab without surgery in the treatment of hidradenitis suppurativa.
EUCTR2016-001663-36-NLErasmus MC, Department of Dermatology
进行中(未招募)
1 期
A comparative trial of either immunotherapy after combined chemo-radiotheraphy, or chemo-radoptherapy alone for patients with limited disease small-cell lung cancer
EUCTR2017-004572-62-DKorwegian University of Science and Technology, Department of Clinical and molecular medicine212
进行中(未招募)
1 期
A randomized phase II study comparing atezolizumab after concurrent chemoradiotherapy with chemoradiotherapy alone in limited disease small-cell lung cancerimited disease small-cell lung cancerMedDRA version: 21.1Level: PTClassification code 10041069Term: Small cell lung cancer limited stageSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2017-004572-62-LTorwegian University of Science and Technology, Department of Clinical and molecular medicine212
进行中(未招募)
1 期
A comparative trial of either immunotherapy after combined chemo-radiotheraphy, or chemo-radoptherapy alone for patients with limited disease small-cell lung cancer (ACHILES study).imited disease small-cell lung cancerMedDRA version: 21.1Level: PTClassification code 10041069Term: Small cell lung cancer limited stageSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2017-004572-62-NLorwegian University of Science and Technology, Department of Clinical and molecular medicine212
招募中
2 期
A randomized phase II study comparing atezolizumab after concurrent chemo-radiotherapy with chemo-radiotherapy alone in limited disease small-cell lung cancer (ACHILES study)cancer
NL-OMON49619orwegian University of Science and Technology100